広尾ありま眼科
HIROO ARIMA EYE CLINIC

日比谷線広尾駅徒歩3分　03-6432-5977

Philosophy Treating patients as if they were members of my own family
Office Hours Mornings 9:30–12:30, afternoons 14:00–18:00
(The reception desk closes 30 minutes before the end of office hours)
Address 1F 5-17-3 Hiroo, Shibuya-ku, Tokyo 150-0012
Treatment Details
  1. Cataract surgery: Inserting multifocal lenses and astigmatism-correcting lenses
  2. Glaucoma surgery: Proposing treatment plans to reduce intraocular pressure
  3. Macular degeneration: Establishing individualized treatment plans
  4. Vitreoretinal surgery: Striving to provide minimally invasive, rapid treatment
  5. Orthokeratology: Restoring visual acuity by wearing contact lenses overnight
  6. Childhood myopia control: Offering advice for preventing the progression of myopia in children
  7. ICL treatment: Restoring visual acuity by inserting contact lenses inside the eye
  8. Hydrogen aspiration: Alleviating oxidative stress to improve the ocular environment
  9. Allergic conjunctivitis: Offering guidance with the initiation of proactive treatment

Requests for patients from countries other than Japan

  • Because the main language in our clinic is Japanese, while we do accept patients of other nationalities, we may take measures such as using a translation device. If at all possible, we recommend that you bring someone with you who can speak Japanese.
  • What to bring on the day (passport, residence card, list of regular medications)
  • We only treat patients who are able to attend the clinic
  • Persons on short-term tourist visas must basically pay 100% of the cost of treatment themselves (cash only)
  • Payment methods: Credit cards accepted, cash payment in Japanese yen only

Message from the Director

I am Dr. Arima, the Director of Hiroo Arima Eye Clinic. For the past 10 years, I have been treating difficult cases in a university hospital. I carry out about 1000 cataract surgeries every year. My clinic provides advanced treatment in Hiroo. Please do not hesitate to get in touch.

Doctor’s Resume

2011 Graduated from Nippon Medical School Faculty of Medicine
Junior Resident, Nippon Medical School Hospital
2013–2015 Senior Resident, Department of Ophthalmology, Nippon Medical School
2014–2018 Graduate School Student, Analytic Human Pathology, Nippon Medical School
2018 Assistant Professor, Department of Ophthalmology, Nippon Medical School
2021 Lecturer, Department of Ophthalmology, Nippon Medical School
2024 Head Doctor, Hiroo Arima Eye Clinic

Papers published by the Director in English

  1. Optical coherence tomography angiography of nonarteritic cilioretinal artery occlusion alone
  2. Changes in tear osmolarity after cataract surgery
  3. Brain-derived neurotrophic factor in human aqueous humor with glaucoma
  4. Changes of the ganglion cell complex in glaucoma patients undergoing inner limiting membrane peeling for epiretinal membrane
  5. Effects of selective peroxisome proliferator-activated receptor agonists on corneal wound healing
  6. Observation of corneal wound healing and angiogenesis using low-vacuum scanning electron microscopy
  7. Hydrogen promotes the activation of Cu, Zn superoxide dismutase 1 in a rat corneal alkali-burn model
  8. Combination of peroxisome proliferator-activated receptor (PPAR) alpha and gamma agonists prevents corneal inflammation and neovascularization in a rat alkali burn model
  9. Peroxisome proliferator-activated receptor beta/delta agonist suppresses inflammation and promotes neovascularization
  10. Effects of hydrogen in prevention of corneal endothelial damage during phacoemulsification: a prospective randomized clinical trial
  11. PPARα agonist suppresses inflammation after corneal alkali burn by suppressing proinflammatory cytokines, MCP-1, and nuclear translocation of NF-κB
  12. Peroxisome proliferator-activated receptor alpha agonist suppresses neovascularization by reducing both vascular endothelial growth factor and angiopoietin-2 in corneal alkali burn
  13. Statistical analysis of factors affecting surgically induced astigmatism following trabeculectomy
  14. Trimebutine prevents corneal inflammation in a rat alkali burn model
  15. Disulfiram ophthalmic solution inhibited macrophage infiltration by suppressing macrophage pseudopodia formation in a rat corneal alkali burn model
  16. Prophylactic instillation of hydrogen-rich water decreases corneal inflammation and promotes wound healing by activating antioxidant activity in a rat alkali burn model
  17. A novel multi-observation system to study the effects of anterior ocular inflammation in Zinn’s zonule using one specimen

Page
Top